Brain pathways to recovery from alcohol dependence

Alcohol

Volumn 49, Issue 5, 2015, Pages 435-452

  Cui, Changhai ^a   Noronha, Antonio ^a   Warren, Kenneth R ^a   Koob, George F ^a,b   Sinha, Rajita ^c   Thakkar, Mahesh ^d   Matochik, John ^a   Crews, Fulton T ^e   Chandler, L Judson ^f   Pfefferbaum, Adolf ^g   Becker, Howard C ^f   Lovinger, David ^a   Everitt, Barry J ^h   Egli, Mark ^a   Mandyam, Chitra D ^b   Fein, George ⁱ   Potenza, Marc N ^c   Harris, R Adron ^j   Grant, Kathleen A ^k   Roberto, Marisa ^b   Meyerhoff, Dieter J ^l   Sullivan, Edith V ^m   more..

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d University of Missouri   (United States)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^g SRI INTERNATIONAL   (United States)

^h UNIVERSITY OF CAMBRIDGE   (United Kingdom)

ⁱ Neurobehavioral Research Inc   (United States)

^j UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^k OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^l UNIVERSITY OF CALIFORNIA   (United States)

^m STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

more..

Author keywords

Abstinence; Alcohol dependence; Neuroadaptation; Neurocircuitry; Recovery; Withdrawal

Indexed keywords

TOLL LIKE RECEPTOR;

AFFECT; ALCOHOL ABSTINENCE; ALCOHOL USE DISORDER; ALCOHOL WITHDRAWAL; ALCOHOLISM; ANTERIOR CINGULATE; ARTICLE; COGNITIVE DEFECT; EMOTIONALITY; EXECUTIVE FUNCTION; GENE EXPRESSION; HOMEOSTASIS; HUMAN; LEARNING DISORDER; MEDIAL PREFRONTAL CORTEX; NERVE CELL NETWORK; NEUROFEEDBACK; NEUROIMAGING; NONHUMAN; RESTING STATE NETWORK; SIGNAL TRANSDUCTION; SLEEP DISORDER; SYMPOSIUM; ADDICTION; BRAIN; COGNITION; DRUG EFFECTS; METABOLISM; NERVE CELL PLASTICITY; NERVE TRACT; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGY; WITHDRAWAL SYNDROME;

ALCOHOLISM; BEHAVIOR, ADDICTIVE; BRAIN; COGNITION; HUMANS; NEURAL PATHWAYS; NEURONAL PLASTICITY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 84930800139     PISSN: 07418329     EISSN: 18736823     Source Type: Journal    
DOI: 10.1016/j.alcohol.2015.04.006     Document Type: Article

References (169)

1. Allen N.J., Barres B.A. Neuroscience: glia - more than just brain glue. Nature 2009, 457:675-677.
2. Anji A., Kumari M. Supplementing the liquid alcohol diet with chow enhances alcohol intake in C57 BL/6 mice. Drug and Alcohol Dependence 2008, 97:86-93.
3. Arnsten A.F. Stress signalling pathways that impair prefrontal cortex structure and function. Nature Reviews. Neuroscience 2009, 10:410-422.
4. Arnsten A.F., Cai J.X., Murphy B.L., Goldman-Rakic P.S. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 1994, 116:143-151.
5. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology (Berl) 1991, 103:227-232.
6. Balodis I.M., Grilo C.M., Kober H., Worhunsky P.D., White M.A., Stevens M.C., et al. Apilot study linking reduced fronto-Striatal recruitment during reward processing to persistent bingeing following treatment for binge-eating disorder. The International Journal of Eating Disorders 2014, 47:376-384.
7. Balodis I.M., Kober H., Worhunsky P.D., Stevens M.C., Pearlson G.D., Potenza M.N. Diminished fronto-striatal activity during processing of monetary rewards and losses in pathological gambling. Biological Psychiatry 2012, 71:749-757.
8. Balodis I.M., Kober H., Worhunsky P.D., White M.A., Stevens M.C., Pearlson G.D., et al. Monetary reward processing in obese individuals with and without binge eating disorder. Biological Psychiatry 2013, 73:877-886.
9. Bechara A. Decision making, impulse control and loss of willpower to resist drugs: a neurocognitive perspective. Nature Neuroscience 2005, 8:1458-1463.
10. Becker H.C. Animal models of excessive alcohol consumption in rodents. Current Topics in Behavioral Neurosciences 2013, 13:355-377.
11. Becker H.C., Lopez M.F. Increased ethanol drinking after repeated chronic ethanol exposure and withdrawal experience in C57BL/6 mice. Alcoholism: Clinical and Experimental Research 2004, 28:1829-1838.
12. Beck A., Schlagenhauf F., Wüstenberg T., Hein J., Kienast T., Kahnt T., et al. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biological Psychiatry 2009, 66:734-742.
13. Beck A., Wüstenberg T., Genauck A., Wrase J., Schlagenhauf F., Smolka M.N., et al. Effect of brain structure, brain function, and brain connectivity on relapse in alcohol-dependent patients. Archives of General Psychiatry 2012, 69:842-852.
14. Belachew S., Chittajallu R., Aguirre A.A., Yuan X., Kirby M., Anderson S., et al. Postnatal NG2 proteoglycan-expressing progenitor cells are intrinsically multipotent and generate functional neurons. The Journal of Cell Biology 2003, 161:169-186.
15. Bentson J., Reza M., Winter J., Wilson G. Steroids and apparent cerebral atrophy on computed tomography scans. Journal of Computer Assisted Tomography 1978, 2:16-23.
16. Borbély A.A. Atwo process model of sleep regulation. Human Neurobiology 1982, 1:195-204.
17. Breese G.R., Overstreet D.H., Knapp D.J., Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 2005, 30:1662-1669.
18. Brewer J.A., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Potenza M.N. Pretreatment brain activation during Stroop task is associated with outcomes in cocaine-dependent patients. Biological Psychiatry 2008, 64:998-1004.
19. Briand L.A., Flagel S.B., Garcia-Fuster M.J., Watson S.J., Akil H., Sarter M., et al. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 2008, 33:2969-2980.
20. Briand L.A., Gross J.P., Robinson T.E. Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration. Neuroscience 2008, 155:1-6.
21. Brower K.J. Alcohol's effects on sleep in alcoholics. Alcohol Research & Health 2001, 25:110-125.
22. Brower K.J. Insomnia, alcoholism and relapse. Sleep Medicine Reviews 2003, 7:523-539.
23. Brower K.J., Perron B.E. Prevalence and correlates of withdrawal-related insomnia among adults with alcohol dependence: results from a national survey. The American Journal on Addictions 2010, 19:238-244.
24. Brower K.J., Perron B.E. Sleep disturbance as a universal risk factor for relapse in addictions to psychoactive substances. Medical Hypotheses 2010, 74:928-933.
25. Butt A.M., Kiff J., Hubbard P., Berry M. Synantocytes: new functions for novel NG2 expressing glia. Journal of Neurocytology 2002, 31:551-565.
26. Camchong J., Stenger A., Fein G. Resting-state synchrony in long-term abstinent alcoholics. Alcoholism: Clinical and Experimental Research 2013, 37:75-85.
27. Camchong J., Stenger V.A., Fein G. Resting state synchrony in long-term abstinent alcoholics with versus without comorbid drug dependence. Drug and Alcohol Dependence 2013, 131:56-65.
28. Camchong J., Stenger V.A., Fein G. Resting-state synchrony in short-term versus long-term abstinent alcoholics. Alcoholism: Clinical and Experimental Research 2013, 37:794-803.
29. Cardinal R.N., Parkinson J.A., Hall J., Everitt B.J. Emotion and motivation: the role of the amygdala, ventral striatum, and prefrontal cortex. Neuroscience and Biobehavioral Reviews 2002, 26:321-352.
30. Chambers R.A., Taylor J.R., Potenza M.N. Developmental neurocircuitry of motivation in adolescence: a critical period of addiction vulnerability. The American Journal of Psychiatry 2003, 160:1041-1052.
31. Choi J.-S., Shin Y.-C., Jung W.H., Jang J.H., Kang D.-H., Choi C.-H., et al. Altered brain activity during reward anticipation in pathological gambling and obsessive-compulsive disorder. PLoS One 2012, 7:e45938.
32. Coleman L.G., He J., Lee J., Styner M., Crews F.T. Adolescent binge drinking alters adult brain neurotransmitter gene expression, behavior, brain regional volumes, and neurochemistry in mice. Alcoholism: Clinical and Experimental Research 2011, 35:671-688.
33. Cools R., D'Esposito M. Inverted-U-shaped dopamine actions on human working memory and cognitive control. Biological Psychiatry 2011, 69:e113-125.
34. Corbit L.H., Nie H., Janak P.H. Habitual alcohol seeking: time course and the contribution of subregions of the dorsal striatum. Biological Psychiatry 2012, 72:389-395.
35. Crews F.T., Qin L., Sheedy D., Vetreno R.P., Zou J. High mobility group box 1/Toll-like receptor danger signaling increases brain neuroimmune activation in alcohol dependence. Biological Psychiatry 2013, 73:602-612.
36. Cuzon Carlson V.C., Seabold G.K., Helms C.M., Garg N., Odagiri M., Rau A.R., et al. Synaptic and morphological neuroadaptations in the putamen associated with long-term, relapsing alcohol drinking in primates. Neuropsychopharmacology 2011, 36:2513-2528.
37. Dawson D.A., Grant B.F., Stinson F.S., Chou P.S., Huang B., Ruan W.J. Recovery from DSM IV alcohol dependence: United States, 2001-2002. Addiction 2005, 100:281-292.
38. Dawson M.R., Polito A., Levine J.M., Reynolds R. NG2-expressing glial progenitor cells: an abundant and widespread population of cycling cells in the adult rat CNS. Molecular and Cellular Neurosciences 2003, 24:476-488.
39. Delfs J.M., Zhu Y., Druhan J.P., Aston-Jones G. Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion. Nature 2000, 403:430-434.
40. DePoy L., Daut R., Brigman J.L., MacPherson K., Crowley N., Gunduz-Cinar O., et al. Chronic alcohol produces neuroadaptations to prime dorsal striatal learning. Proceedings of the National Academy of Sciences of the United States of America 2013, 110:14783-14788.
41. DeVito E.E., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Kober H., Potenza M.N. Apreliminary study of the neural effects of behavioral therapy for substance use disorders. Drug and Alcohol Dependence 2012, 122:228-235.
42. Duka T., Trick L., Nikolaou K., Gray M.A., Kempton M.J., Williams H., et al. Unique brain areas associated with abstinence control are damaged in multiply detoxified alcoholics. Biological Psychiatry 2011, 70:545-552.
43. Dunn A.J., Berridge C.W. Is corticotropin-releasing factor a mediator of stress responses?. Annals of the New York Academy of Sciences 1990, 579:183-191.
44. Enzmann D.R., Lane B. Cranial computed tomography findings in anorexia nervosa. Journal of Computer Assisted Tomography 1977, 1:410-414.
45. Everitt B.J., Dickinson A., Robbins T.W. The neuropsychological basis of addictive behaviour. Brain Research. Brain Research Reviews 2001, 36:129-138.
46. Everitt B.J., Robbins T.W. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nature Neuroscience 2005, 8:1481-1489.
47. Fields R.D. Myelination: an overlooked mechanism of synaptic plasticity?. Neuroscientist 2005, 11:528-531.
48. Fields R.D. Neuroscience. Change in the brain's white matter. Science 2010, 330:768-769.
49. Fineberg N.A., Chamberlain S.R., Goudriaan A.E., Stein D.J., Vanderschuren L.J., Gillan C.M., et al. New developments in human neurocognition: clinical, genetic, and brain imaging correlates of impulsivity and compulsivity. CNS Spectrums 2014, 19:69-89.
50. Funk C.K., O'Dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. The Journal of Neuroscience 2006, 26:11324-11332.
51. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biological Psychiatry 2007, 61:78-86.
52. Gao W.J., Wang Y., Goldman-Rakic P.S. Dopamine modulation of perisomatic and peridendritic inhibition in prefrontal cortex. The Journal of Neuroscience 2003, 23:1622-1630.
53. Gehlert D.R., Cippitelli A., Thorsell A., Lê A.D., Hipskind P.A., Hamdouchi C., et al. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. The Journal of Neuroscience 2007, 27:2718-2726.
54. George O., Mandyam C.D., Wee S., Koob G.F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 2008, 33:2474-2482.
55. George O., Sanders C., Freiling J., Grigoryan E., Vu S., Allen C.D., et al. Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proceedings of the National Academy of Sciences of the United States of America 2012, 109:18156-18161.
56. Grant B.F., Dawson D.A. Age at onset of alcohol use and its association with DSM-IV alcohol abuse and dependence: results from the National Longitudinal Alcohol Epidemiologic Survey. Journal of Substance Abuse 1997, 9:103-110.
57. Griffin W.C., Lopez M.F., Yanke A.B., Middaugh L.D., Becker H.C. Repeated cycles of chronic intermittent ethanol exposure in mice increases voluntary ethanol drinking and ethanol concentrations in the nucleus accumbens. Psychopharmacology (Berl) 2009, 201:569-580.
58. Holt J.L., Kraft-Terry S.D., Chang L. Neuroimaging studies of the aging HIV-1-infected brain. Journal of Neurovirology 2012, 18:291-302.
59. Huang M.M., Overstreet D.H., Knapp D.J., Angel R., Wills T.A., Navarro M., et al. Corticotropin-releasing factor (CRF) sensitization of ethanol withdrawal-induced anxiety-like behavior is brain site specific and mediated by CRF-1 receptors: relation to stress-induced sensitization. The Journal of Pharmacology and Experimental Therapeutics 2010, 332:298-307.
60. Hutchinson M.R., Zhang Y., Brown K., Coats B.D., Shridhar M., Sholar P.W., et al. Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4). The European Journal of Neuroscience 2008, 28:20-29.
61. Jia Z., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Stevens M.C., Pearlson G.D., et al. An initial study of neural responses to monetary incentives as related to treatment outcome in cocaine dependence. Biological Psychiatry 2011, 70:553-560.
62. Kalivas P.W., O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacology 2008, 33:166-180.
63. Kang S.H., Fukaya M., Yang J.K., Rothstein J.D., Bergles D.E. NG2+ CNS glial progenitors remain committed to the oligodendrocyte lineage in postnatal life and following neurodegeneration. Neuron 2010, 68:668-681.
64. Kim A., Zamora-Martinez E.R., Edwards S., Mandyam C.D. Structural reorganization of pyramidal neurons in the medial prefrontal cortex of alcohol dependent rats is associated with altered glial plasticity. Brain Structure & Function 2014, 220:1705-1720.
65. Knapp D.J., Overstreet D.H., Moy S.S., Breese G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 2004, 32:101-111.
66. Koob G.F. Arole for brain stress systems in addiction. Neuron 2008, 59:11-34.
67. Koob G.F. Neurobiological substrates for the dark side of compulsivity in addiction. Neuropharmacology 2009, 56(Suppl. 1):18-31.
68. Koob G.F. Theoretical frameworks and mechanistic aspects of alcohol addiction: alcohol addiction as a reward deficit disorder. Current Topics in Behavioral Neurosciences 2013, 13:3-30.
69. Koob G.F., Ahmed S.H., Boutrel B., Chen S.A., Kenny P.J., Markou A., et al. Neurobiological mechanisms in the transition from drug use to drug dependence. Neuroscience and Biobehavioral Reviews 2004, 27:739-749.
70. Koob G.F., Heinrichs S.C., Menzaghi F., Pich E.M., Britton K.T. Corticotropin releasing factor, stress and behavior. Seminars in Neuroscience 1994, 6:221-229.
71. Koob G., Kreek M.J. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. The American Journal of Psychiatry 2007, 164:1149-1159.
72. Koob G.F., Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 1997, 278:52-58.
73. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
74. Koob G.F., Le Moal M. Addiction and the brain antireward system. Annual Review of Psychology 2008, 59:29-53.
75. Krishnan-Sarin S., Balodis I.M., Kober H., Worhunsky P.D., Liss T., Xu J., et al. An exploratory pilot study of the relationship between neural correlates of cognitive control and reduction in cigarette use among treatment-seeking adolescent smokers. Psychology of Addictive Behaviors 2013, 27:526-532.
76. Kroener S., Mulholland P.J., New N.N., Gass J.T., Becker H.C., Chandler L.J. Chronic alcohol exposure alters behavioral and synaptic plasticity of the rodent prefrontal cortex. PLoS One 2012, 7:e37541.
77. Kroenke C.D., Rohlfing T., Park B., Sullivan E.V., Pfefferbaum A., Grant K.A. Monkeys that voluntarily and chronically drink alcohol damage their brains: a longitudinal MRI study. Neuropsychopharmacology 2014, 39:823-830.
78. Lee J.L., Di Ciano P., Thomas K.L., Everitt B.J. Disrupting reconsolidation of drug memories reduces cocaine-seeking behavior. Neuron 2005, 47:795-801.
79. Lee J.L., Milton A.L., Everitt B.J. Cue-induced cocaine seeking and relapse are reduced by disruption of drug memory reconsolidation. The Journal of Neuroscience 2006, 26:5881-5887.
80. Lemos J.C., Wanat M.J., Smith J.S., Reyes B.A., Hollon N.G., Van Bockstaele E.J., et al. Severe stress switches CRF action in the nucleus accumbens from appetitive to aversive. Nature 2012, 490:402-406.
81. Ligon K.L., Kesari S., Kitada M., Sun T., Arnett H.A., Alberta J.A., et al. Development of NG2 neural progenitor cells requires Olig gene function. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:7853-7858.
82. Lopez M.F., Becker H.C. Effect of pattern and number of chronic ethanol exposures on subsequent voluntary ethanol intake in C57BL/6J mice. Psychopharmacology (Berl) 2005, 181:688-696.
83. Lubin F.D., Gupta S., Parrish R.R., Grissom N.M., Davis R.L. Epigenetic mechanisms: critical contributors to long-term memory formation. Neuroscientist 2011, 17:616-632.
84. Majchrowicz E. Induction of physical dependence upon ethanol and the associated behavioral changes in rats. Psychopharmacologia 1975, 43:245-254.
85. Mameli M., Lüscher C. Synaptic plasticity and addiction: learning mechanisms gone awry. Neuropharmacology 2011, 61:1052-1059.
86. Mandyam C.D., Koob G.F. The addicted brain craves new neurons: putative role for adult-born progenitors in promoting recovery. Trends in Neurosciences 2012, 35:250-260.
87. Maroso M., Balosso S., Ravizza T., Liu J., Aronica E., Iyer A.M., et al. Toll-like receptor 4 and high-mobility group box-1 are involved in ictogenesis and can be targeted to reduce seizures. Nature Medicine 2010, 16:413-419.
88. Martinez D., Carpenter K.M., Liu F., Slifstein M., Broft A., Friedman A.C., et al. Imaging dopamine transmission in cocaine dependence: link between neurochemistry and response to treatment. The American Journal of Psychiatry 2011, 168:634-641.
89. Melendez R.I., McGinty J.F., Kalivas P.W., Becker H.C. Brain region-specific gene expression changes after chronic intermittent ethanol exposure and early withdrawal in C57BL/6J mice. Addiction Biology 2012, 17:351-364.
90. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez de Fonseca F., Raber J., Koob G.F., et al. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. The Journal of Neuroscience 1995, 15:5439-5447.
91. Milton A.L., Everitt B.J. The psychological and neurochemical mechanisms of drug memory reconsolidation: implications for the treatment of addiction. The European Journal of Neuroscience 2010, 31:2308-2319.
92. Milton A.L., Lee J.L., Butler V.J., Gardner R., Everitt B.J. Intra-amygdala and systemic antagonism of NMDA receptors prevents the reconsolidation of drug-associated memory and impairs subsequently both novel and previously acquired drug-seeking behaviors. The Journal of Neuroscience 2008, 28:8230-8237.
93. Milton A.L., Lee J.L., Everitt B.J. Reconsolidation of appetitive memories for both natural and drug reinforcement is dependent on {beta}-adrenergic receptors. Learning & Memory 2008, 15:88-92.
94. Milton A.L., Schramm M.J., Wawrzynski J.R., Gore F., Oikonomou-Mpegeti F., Wang N.Q., et al. Antagonism at NMDA receptors, but not β-adrenergic receptors, disrupts the reconsolidation of pavlovian conditioned approach and instrumental transfer for ethanol-associated conditioned stimuli. Psychopharmacology (Berl) 2012, 219:751-761.
95. Mitchell M.R., Balodis I.M., DeVito E.E., Lacadie C.M., Yeston J., Scheinost D., et al. Apreliminary investigation of Stroop-related intrinsic connectivity in cocaine dependence: associations with treatment outcomes. The American Journal of Drug and Alcohol Abuse 2013, 39:392-402.
96. Müller-Oehring E.M., Schulte T., Rohlfing T., Pfefferbaum A., Sullivan E.V. Visual search and the aging brain: discerning the effects of age-related brain volume shrinkage on alertness, feature binding, and attentional control. Neuropsychology 2013, 27:48-59.
97. Nader K., Schafe G.E., Le Doux J.E. Fear memories require protein synthesis in the amygdala for reconsolidation after retrieval. Nature 2000, 406:722-726.
98. O'Dell L.E., Roberts A.J., Smith R.T., Koob G.F. Enhanced alcohol self-administration after intermittent versus continuous alcohol vapor exposure. Alcoholism: Clinical and Experimental Research 2004, 28:1676-1682.
99. Olive M.F., Koenig H.N., Nannini M.A., Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacology, Biochemistry, and Behavior 2002, 72:213-220.
100. Overstreet D.H., Knapp D.J., Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacology, Biochemistry, and Behavior 2004, 77:405-413.
101. Overstreet D.H., Knapp D.J., Breese G.R. Drug challenges reveal differences in mediation of stress facilitation of voluntary alcohol drinking and withdrawal-induced anxiety in alcohol-preferring P rats. Alcoholism: Clinical and Experimental Research 2007, 31:1473-1481.
102. Peixoto L., Abel T. The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 2013, 38:62-76.
103. Peters J., Bromberg U., Schneider S., Brassen S., Menz M., Banaschewski T., et al. Lower ventral striatal activation during reward anticipation in adolescent smokers. The American Journal of Psychiatry 2011, 168:540-549.
104. Pfefferbaum A., Rogosa D.A., Rosenbloom M.J., Chu W., Sassoon S.A., Kemper C.A., et al. Accelerated aging of selective brain structures in human immunodeficiency virus infection: a controlled, longitudinal magnetic resonance imaging study. Neurobiology of Aging 2014, 35:1755-1768.
105. Pfefferbaum A., Rosenbloom R.J., Chu W., Sassoon S.A., Rohlfing T., Pohl K.M., et al. White matter microstructural recovery with abstinence and decline with relapse in alcohol dependence interacts with normal ageing: a controlled longitudinal DTI study. The Lancet Psychiatry 2014, 1:202-212.
106. Pfefferbaum A., Zahr N.M., Mayer D., Vinco S., Orduna J., Rohlfing T., et al. Ventricular expansion in wild-type Wistar rats after alcohol exposure by vapor chamber. Alcoholism: Clinical and Experimental Research 2008, 32:1459-1467.
107. Porkka-Heiskanen T., Zitting K.M., Wigren H.K. Sleep, its regulation and possible mechanisms of sleep disturbances. Acta Physiologica (Oxf) 2013, 208:311-328.
108. Potenza M.N., Balodis I.M., Franco C.A., Bullock S., Xu J., Chung T., et al. Neurobiological considerations in understanding behavioral treatments for pathological gambling. Psychology of Addictive Behaviors 2013, 27:380-392.
109. Potenza M.N., Sofuoglu M., Carroll K.M., Rounsaville B.J. Neuroscience of behavioral and pharmacological treatments for addictions. Neuron 2011, 69:695-712.
110. Qin L., Crews F.T. Chronic ethanol increases systemic TLR3 agonist-induced neuroinflammation and neurodegeneration. Journal of Neuroinflammation 2012, 9:130.
111. Qin L., Liu Y., Hong J.S., Crews F.T. NADPH oxidase and aging drive microglial activation, oxidative stress, and dopaminergic neurodegeneration following systemic LPS administration. Glia 2013, 61:855-868.
112. Qin L., Wu X., Block M.L., Liu Y., Breese G.R., Hong J.S., et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 2007, 55:453-462.
113. Rainnie D.G., Bergeron R., Sajdyk T.J., Patil M., Gehlert D.R., Shekhar A. Corticotrophin releasing factor-induced synaptic plasticity in the amygdala translates stress into emotional disorders. The Journal of Neuroscience 2004, 24:3471-3479.
114. Rasmussen D.D., Boldt B.M., Bryant C.A., Mitton D.R., Larsen S.A., Wilkinson C.W. Chronic daily ethanol and withdrawal: 1. Long-term changes in the hypothalamo-pituitary-adrenal axis. Alcoholism: Clinical and Experimental Research 2000, 24:1836-1849.
115. Rassnick S., Heinrichs S.C., Britton K.T., Koob G.F. Microinjection of a corticotropin-releasing factor antagonist into the central nucleus of the amygdala reverses anxiogenic-like effects of ethanol withdrawal. Brain Research 1993, 605:25-32.
116. Rhodes J.S., Best K., Belknap J.K., Finn D.A., Crabbe J.C. Evaluation of a simple model of ethanol drinking to intoxication in C57BL/6J mice. Physiology & Behavior 2005, 84:53-63.
117. Richardson H.N., Chan S.H., Crawford E.F., Lee Y.K., Funk C.K., Koob G.F., et al. Permanent impairment of birth and survival of cortical and hippocampal proliferating cells following excessive drinking during alcohol dependence. Neurobiology of Disease 2009, 36:1-10.
118. Rimondini R., Arlinde C., Sommer W., Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB Journal 2002, 16:27-35.
119. Rivers L.E., Young K.M., Rizzi M., Jamen F., Psachoulia K., Wade A., et al. PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice. Nature Neuroscience 2008, 11:1392-1401.
120. Rivier C., Bruhn T., Vale W. Effect of ethanol on the hypothalamic-pituitary-adrenal axis in the rat: role of corticotropin-releasing factor (CRF). The Journal of Pharmacology and Experimental Therapeutics 1984, 229:127-131.
121. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., et al. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biological Psychiatry 2010, 67:831-839.
122. Roehrs T., Roth T. Sleep, sleepiness, and alcohol use. Alcohol Research & Health 2001, 25:101-109.
123. Roehrs T., Roth T. Sleep, sleepiness, sleep disorders and alcohol use and abuse. Sleep Medicine Reviews 2001, 5:287-297.
124. Sanchez H., Quinn J.J., Torregrossa M.M., Taylor J.R. Reconsolidation of a cocaine-associated stimulus requires amygdalar protein kinase A. The Journal of Neuroscience 2010, 30:4401-4407.
125. Sarnyai Z., Shaham Y., Heinrichs S.C. The role of corticotropin-releasing factor in drug addiction. Pharmacological Reviews 2001, 53:209-243.
126. Scheinost D., Benjamin J., Lacadie C.M., Vohr B., Schneider K.C., Ment L.R., et al. The intrinsic connectivity distribution: a novel contrast measure reflecting voxel level functional connectivity. NeuroImage 2012, 62:1510-1519.
127. Seo D., Lacadie C.M., Tuit K., Hong K.I., Constable R.T., Sinha R. Disrupted ventromedial prefrontal function, alcohol craving, and subsequent relapse risk. JAMA Psychiatry 2013, 70:727-739.
128. Sharma R., Engemann S., Sahota P., Thakkar M.M. Role of adenosine and wake-promoting basal forebrain in insomnia and associated sleep disruptions caused by ethanol dependence. Journal of Neurochemistry 2010, 115:782-794.
129. Sharma R., Engemann S.C., Sahota P., Thakkar M.M. Effects of ethanol on extracellular levels of adenosine in the basal forebrain: an invivo microdialysis study in freely behaving rats. Alcoholism: Clinical and Experimental Research 2010, 34:813-818.
130. Sharma R., Sahota P., Thakkar M.M. Alcohol and sleep. Encyclopedia of sleep and dreams: the evolution, function, nature, and mysteries of slumber 2012, 23-24. Greenwood, Santa Barbara, CA. D. Barrett, P. McNamara (Eds.).
131. Sinha R. How does stress increase risk of drug abuse and relapse?. Psychopharmacology (Berl) 2001, 158:343-359.
132. Sinha R. Chronic stress, drug use, and vulnerability to addiction. Annals of the New York Academy of Sciences 2008, 1141:105-130.
133. Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Current Psychiatry Reports 2011, 13:398-405.
134. Slutske W.S., Eisen S., True W.R., Lyons M.J., Goldberg J., Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Archives of General Psychiatry 2000, 57:666-673.
135. Somkuwar S.S., Staples M.C., Galinato M.H., Fannon M.J., Mandyam C.D. Role of NG2 expressing cells in addiction: a new approach for an old problem. Frontiers in Pharmacology 2014, 5:279.
136. Spudich S.S., Ances B.M. Neurologic complications of HIV infection. Topics in Antiviral Medicine 2012, 20:41-47.
137. Sullivan E.V., Müller-Oehring E., Pitel A.L., Chanraud S., Shankaranarayanan A., Alsop D.C., et al. Aselective insular perfusion deficit contributes to compromised salience network connectivity in recovering alcoholic men. Biological Psychiatry 2013, 74:547-555.
138. Sullivan E.V., Pfefferbaum A. Neurocircuitry in alcoholism: a substrate of disruption and repair. Psychopharmacology (Berl) 2005, 180:583-594.
139. Sun Y., Meijer D.H., Alberta J.A., Mehta S., Kane M.F., Tien A.C., et al. Phosphorylation state of Olig2 regulates proliferation of neural progenitors. Neuron 2011, 69:906-917.
140. Thakkar M.M., Delgiacco R.A., Strecker R.E., McCarley R.W. Adenosinergic inhibition of basal forebrain wakefulness-active neurons: a simultaneous unit recording and microdialysis study in freely behaving cats. Neuroscience 2003, 122:1107-1113.
141. Thakkar M.M., Engemann S.C., Sharma R., Sahota P. Role of wake-promoting basal forebrain and adenosinergic mechanisms in sleep-promoting effects of ethanol. Alcoholism: Clinical and Experimental Research 2010, 34:997-1005.
142. Thakkar M.M., Sharma R., Sahota P. Alcohol disrupts sleep homeostasis. Alcohol 2015, 49:299-310.
143. Thakkar M.M., Winston S., McCarley R.W. A1 receptor and adenosinergic homeostatic regulation of sleep-wakefulness: effects of antisense to the A1 receptor in the cholinergic basal forebrain. The Journal of Neuroscience 2003, 23:4278-4287.
144. Trantham-Davidson H., Burnett E.J., Gass J.T., Lopez M.F., Mulholland P.J., Centanni S.W., et al. Chronic alcohol disrupts dopamine receptor activity and the cognitive function of the medial prefrontal cortex. The Journal of Neuroscience 2014, 34:3706-3718.
145. Tsuang M., Lyons M.J., Meyer J.M., Doyle T., Eisen S.A., Goldberg J., et al. Co-occurrence of abuse of different drugs in men: the role of drug-specific and shared vulnerabilities. Archives of General Psychiatry 1998, 55:967-972.
146. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., et al. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcoholism: Clinical and Experimental Research 2002, 26:1494-1501.
147. Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29:55-60.
148. Vendruscolo L.F., Barbier E., Schlosburg J.E., Misra K.K., Whitfield T.W., Logrip M.L., et al. Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. The Journal of Neuroscience 2012, 32:7563-7571.
149. Vetreno R.P., Crews F.T. Adolescent binge drinking increases expression of the danger signal receptor agonist HMGB1 and Toll-like receptors in the adult prefrontal cortex. Neuroscience 2012, 226:475-488.
150. Vetreno R.P., Qin L., Crews F.T. Increased receptor for advanced glycation end product expression in the human alcoholic prefrontal cortex is linked to adolescent drinking. Neurobiology of Disease 2013, 59:52-62.
151. Volkow N.D., Li T.-K. Drug addiction: the neurobiology of behaviour gone awry. Nature Reviews. Neuroscience 2004, 5:963-970.
152. Volkow N.D., Wang G.J., Begleiter H., Porjesz B., Fowler J.S., Telang F., et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Archives of General Psychiatry 2006, 63:999-1008.
153. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Hitzemann R., Ding Y.S., et al. Decreases in dopamine receptors but not in dopamine transporters in alcoholics. Alcoholism: Clinical and Experimental Research 1996, 20:1594-1598.
154. Volkow N.D., Wang G.J., Tomasi D., Baler R.D. Unbalanced neuronal circuits in addiction. Current Opinion in Neurobiology 2013, 23:639-648.
155. Watanabe M., Toyama Y., Nishiyama A. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. Journal of Neuroscience Research 2002, 69:826-836.
156. Wilcox M.V., Cuzon Carlson V.C., Sherazee N., Sprow G.M., Bock R., Thiele T.E., et al. Repeated binge-like ethanol drinking alters ethanol drinking patterns and depresses striatal GABAergic transmission. Neuropsychopharmacology 2014, 39:579-594.
157. Wills T.A., Knapp D.J., Overstreet D.H., Breese G.R. Sensitization, duration, and pharmacological blockade of anxiety-like behavior following repeated ethanol withdrawal in adolescent and adult rats. Alcoholism: Clinical and Experimental Research 2009, 33:455-463.
158. Worhunsky P.D., Stevens M.C., Carroll K.M., Rounsaville B.J., Calhoun V.D., Pearlson G.D., et al. Functional brain networks associated with cognitive control, cocaine dependence, and treatment outcome. Psychology of Addictive Behaviors 2013, 27:477-488.
159. Wrase J., Schlagenhauf F., Kienast T., Wüstenberg T., Bermpohl F., Kahnt T., et al. Dysfunction of reward processing correlates with alcohol craving in detoxified alcoholics. NeuroImage 2007, 35:787-794.
160. Xu J., DeVito E.E., Worhunsky P.D., Carroll K.M., Rounsaville B.J., Potenza M.N. White matter integrity is associated with treatment outcome measures in cocaine dependence. Neuropsychopharmacology 2010, 35:1541-1549.
161. Xue Y.X., Luo Y.X., Wu P., Shi H.S., Xue L.F., Chen C., et al. Amemory retrieval-extinction procedure to prevent drug craving and relapse. Science 2012, 336:241-245.
162. Xu J., Potenza M.N., Calhoun V.D. Spatial ICA reveals functional activity hidden from traditional fMRI GLM-based analyses. Frontiers in Neuroscience 2013, 7:154.
163. Yip S.W., DeVito E.E., Kober H., Worhunsky P.D., Carroll K.M., Potenza M.N. Pretreatment measures of brain structure and reward-processing brain function in cannabis dependence: an exploratory study of relationships with abstinence during behavioral treatment. Drug and Alcohol Dependence 2014, 140:33-41.
164. Zahr N.M., Mayer D., Rohlfing T., Hasak M., Hsu O., Vinco S., et al. Brain injury and recovery following binge ethanol: evidence from invivo magnetic resonance spectroscopy. Biological Psychiatry 2010, 67:846-854.
165. Zahr N.M., Mayer D., Rohlfing T., Hsu O., Vinco S., Orduna J., et al. Rat strain differences in brain structure and neurochemistry in response to binge alcohol. Psychopharmacology (Berl) 2013, 231:429-445.
166. Zahr N.M., Mayer D., Rohlfing T., Orduna J., Luong R., Sullivan E.V., et al. Amechanism of rapidly reversible cerebral ventricular enlargement independent of tissue atrophy. Neuropsychopharmacology 2013, 38:1121-1129.
167. Zahr N.M., Mayer D., Vinco S., Orduna J., Luong R., Sullivan E.V., et al. Invivo evidence for alcohol-induced neurochemical changes in rat brain without protracted withdrawal, pronounced thiamine deficiency, or severe liver damage. Neuropsychopharmacology 2009, 34:1427-1442.
168. Zipursky R.B., Lim K.C., Pfefferbaum A. MRI study of brain changes with short-term abstinence from alcohol. Alcoholism: Clinical and Experimental Research 1989, 13:664-666.
169. Zou J.Y., Crews F.T. Release of neuronal HMGB1 by ethanol through decreased HDAC activity activates brain neuroimmune signaling. PLoS One 2014, 9:e87915.